CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9180161
APP PUB NO 20130196896A1
SERIAL NO

13581457

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are compositions and methods useful for delivering targeted therapies for pulmonary diseases, fibrotic disorders and cancer. The compositions and methods are based on peptide sequences that selectively bind to and home to diseased tissue and enable targeted therapies to effect a beneficial therapeutic result. The disclosed targeting is useful for delivering therapeutic and detectable agents to diseased tissue in an animal.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE;VASCULAR BIOSCIENCES;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Komatsu, Masanobu Orlando, US 9 54
Mann, David Marshall San Diego, US 3 117
Ruoslahti, Erkki Busilton, US 115 2304

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00